CD8A and hepatocellular carcinoma: Model 4 (LR: 61.5) was achieved by adding CD8+ cell density profiles at the HCC interface to model 3: a higher standard deviation of CD8+ density within the tumor edge improved OS (HR: 0.41, p = 0.0026).